TY - JOUR
T1 - Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq
AU - Mody, Rupal M.
AU - Lakhal-Naouar, Ines
AU - Sherwood, Jeffrey E.
AU - Koles, Nancy L.
AU - Shaw, Dutchabong
AU - Bigley, Daniel P.
AU - Co, Edgie Mark A.
AU - Copeland, Nathanial K.
AU - Jagodzinski, Linda L.
AU - Mukbel, Rami M.
AU - Smiley, Rebecca A.
AU - Duncan, Robert C.
AU - Kamhawi, Shaden
AU - Jeronimo, Selma M.B.
AU - Defraites, Robert F.
AU - Aronson, Naomi E.
N1 - Publisher Copyright:
© 2018 Published by Oxford University Press for the Infectious Diseases Society of America 2018.
PY - 2019/6
Y1 - 2019/6
N2 - Background: Visceral leishmaniasis (VL), due to Leishmania infantum, is a persistent intracellular parasitic infection transmitted by the bite of infected sand flies. Symptomatic VL has been reported in U.S. soldiers with Iraq deployment. Untreated symptomatic VL can be fatal; asymptomatic VL (AVL) may establish a lifelong risk of reactivation. We report prevalence and AVL risk factors in Operation Iraqi Freedom (OIF) deployers during 2002-11. Methods: Healthy soldiers exposed to VL endemic areas in Iraq and 50 controls who never traveled to endemic regions were recruited through military healthcare facilities (2015-17). Responses to a risk factor survey and blood samples were obtained. Leishmania research diagnostics utilized included enzyme-linked immunosorbent assay (ELISA), rk39 test strips, quantitative polymerase chain reaction (PCR), and interferon gamma release (IGRA) assays. Statistical analyses included Fisher exact test, Pearson χ2 test, Mann-Whitney U test, and logistic regression. Results: 200 deployed subjects were enrolled, mostly males (84.0%), of white ethnicity (79.0%), and median age 41 (range 24-61) years. 64% were seropositive for Phlebotomus alexandri saliva antibodies. Prevalence of AVL (any positive test result) was 39/200 (19.5%, 95% confidence interval 14.4%-25.8%). Two (1.0%) PCR, 10 (5%) ELISA, and 28 (14%) IGRA samples were positive. Travel to Ninewa governorate increased risk for AVL (P =. 01). Conclusion: AVL was identified in 19.5% of OIF deployers; travel to northwest Iraq correlated with infection. Further studies are needed to inform risk for reactivation VL in US veterans and to target additional blood safety and surveillance measures.
AB - Background: Visceral leishmaniasis (VL), due to Leishmania infantum, is a persistent intracellular parasitic infection transmitted by the bite of infected sand flies. Symptomatic VL has been reported in U.S. soldiers with Iraq deployment. Untreated symptomatic VL can be fatal; asymptomatic VL (AVL) may establish a lifelong risk of reactivation. We report prevalence and AVL risk factors in Operation Iraqi Freedom (OIF) deployers during 2002-11. Methods: Healthy soldiers exposed to VL endemic areas in Iraq and 50 controls who never traveled to endemic regions were recruited through military healthcare facilities (2015-17). Responses to a risk factor survey and blood samples were obtained. Leishmania research diagnostics utilized included enzyme-linked immunosorbent assay (ELISA), rk39 test strips, quantitative polymerase chain reaction (PCR), and interferon gamma release (IGRA) assays. Statistical analyses included Fisher exact test, Pearson χ2 test, Mann-Whitney U test, and logistic regression. Results: 200 deployed subjects were enrolled, mostly males (84.0%), of white ethnicity (79.0%), and median age 41 (range 24-61) years. 64% were seropositive for Phlebotomus alexandri saliva antibodies. Prevalence of AVL (any positive test result) was 39/200 (19.5%, 95% confidence interval 14.4%-25.8%). Two (1.0%) PCR, 10 (5%) ELISA, and 28 (14%) IGRA samples were positive. Travel to Ninewa governorate increased risk for AVL (P =. 01). Conclusion: AVL was identified in 19.5% of OIF deployers; travel to northwest Iraq correlated with infection. Further studies are needed to inform risk for reactivation VL in US veterans and to target additional blood safety and surveillance measures.
KW - Iraq
KW - US soldiers
KW - asymptomatic
KW - deployed
KW - visceral leishmaniasis
UR - http://www.scopus.com/inward/record.url?scp=85067281944&partnerID=8YFLogxK
U2 - 10.1093/cid/ciy811
DO - 10.1093/cid/ciy811
M3 - Article
C2 - 30239631
AN - SCOPUS:85067281944
SN - 1058-4838
VL - 68
SP - 2036
EP - 2044
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 12
M1 - ciy811
ER -